Esperion Therapeutics Inc (NASDAQ:ESPR) currently has a daily average trading volume of 5.39M but it saw 4501259 shares traded in last market. With a market cap of 169.06M USD, the company’s current market price of $0.85 came falling about -6.13 while comparing to the previous closing price of $0.91. In past 52 weeks, the stock remained buoying in the range of price level as high as $3.94 and as low as $0.69.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Goldman which initiated the stock as “Neutral” in its note to investors issued on December 18, 2024, recommending a price target of $4 for it. BofA Securities issued its recommendations for the stock as it downgraded the price target for the stock is $2.50.
Over the week, ESPR’s stock price is moving 16.85% up while it is -8.25% when we observe its performance for the past one month. Year-to-date it is -61.23% down and over the past year, the stock is showing a downside performance of -63.86%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of -0.19 while estimate for next year EPS is -0.44. In next quarter, company is expected to be making quarterly sales of $92.41M as analysts are expecting the sales for current fiscal year at $344.17M and seeing the company making $328.28M in sales next year. Moreover, analysts are in estimates of $62.55M for current-quarter revenue.
Currently, Esperion Therapeutics Inc’s total number of outstanding shares is 196.66M with 0.51% of that held by the insiders while 59.28% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -288.75%. Stock’s beta reads 0.68. Stock has a price to sale or P/S ratio amounts to 0.65. Its return on asset (ROA) is -43.96% on average.
